Emeis Stock Falls 3.75% and Slides Among the Biggest Declines of the SBF 120
The healthcare services group's stock drops mid-session, contrary to the bullish movement observed at the end of last week. The stock is among the biggest losers in the SBF 120 in a declining Parisian market, on the eve of a statutory meeting for the group.
The stock falls below its three moving averages and erases its Friday rebound
Emeis loses 3.75% to €13.86 at midday, after having closed at €14.40 on Friday. The session largely erases the 2.5% rebound praised at the end of last week, placing the stock among the biggest declines of the SBF 120, while the index itself is down 0.75% during the session. The price falls below its MM20 (€14.29) and MM50 (€14.36), with a gap of about 3% in both cases. It also just falls below its MM200 at €13.93, 0.5% below, bringing the technical debate back to this medium-term level. The identified support at €13.64 is now immediately within reach of the price. The RSI at 54 remains neutral and does not yet send a signal of exhaustion of the selling pressure.
A general meeting expected on Tuesday, the last short-term calendar marker
The group's financial calendar highlights the 2026 general meeting, scheduled for June 23, which is tomorrow. This statutory meeting remains a calendar point and not a price driver in itself. Regarding recent performance, the stock has lost 2.19% over the week and 5.39% over the month, while still maintaining a gain of 25.77% over the year. Meanwhile, the market context weighs on the Paris session, in an environment where major central banks have toughened their stance and tensions around the Strait of Hormuz fuel volatility. Nevertheless, the VIX falls nearly 5% to 17.53. In the short term, the maintenance of the support at €13.64 and the behavior of the price around the MM200 at €13.93 will be the levels to watch.
